Taiwan FDA registration 0f30d674f68cff5f5b9ab0536c861118
GE GlucoCapture blood glucose monitoring system
TW: GE GlucoCapture血糖監測系統
Taiwan·Risk Class 2·Daqing Factory of Huaguang Biotechnology Co., Ltd·Registered Apr 21, 2022 – Apr 21, 2027ActiveRegistration details
- Analysis ID
- 0f30d674f68cff5f5b9ab0536c861118
Company information
- Manufacturer Country
- Taiwan, Province of China
- Authorized Representative
- Daqing Factory of Huaguang Biotechnology Co., Ltd
Product details
- Intended Use
- The blood glucose machine of the GE GlucoCapture blood glucose monitoring system needs to be used with the corresponding model of blood glucose test piece, which can measure fingertips, palms or arm microvessels, veins, arteries and neonatal whole blood.
- Product Type (Level 1)
- A Clinical chemistry and clinical toxicology
- Product Type (Level 2)
- A.1345 Glucose Test System
- Import Information
- 國產;; QMS/QSD
Dates and status
- Registration Date
- Apr 21, 2022
- Expiry Date
- Apr 21, 2027
About this record
Access comprehensive regulatory information for GE GlucoCapture blood glucose monitoring system in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number 0f30d674f68cff5f5b9ab0536c861118 and manufactured by Daqing Factory of Huaguang Biotechnology Co., Ltd. The authorized representative in Taiwan is Daqing Factory of Huaguang Biotechnology Co., Ltd.
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Free DatabasePowered by Pure Global AI89,000+ Devices